# AI-driven biotech partnership expansion > Live situation record from CLSTR: https://clstr.news/situations/ai-driven-biotech-partnership-expansion > Updated: 2026-08-06T06:17:40.000Z. Sources: 4. Developments: 2. In late July 2026, Evogene partnered with South Korean biotech ELEO to apply Evogene’s ChemPass AI platform to discover oral PCSK9 inhibitors, while German drug‑discovery firm Evotec announced a joint effort with U.S. company QIAGEN to merge QIAGEN’s OmicSoft data libraries with Evotec’s PanHunter analysis software. Both deals highlighted the use of artificial‑intelligence‑enabled computational chemistry and multi‑omics analytics to speed drug‑development pipelines. A few weeks later, in early August 2026, Evotec broadened its AI‑driven discovery model by opening its platform to Odyssey Therapeutics. The agreement enables Odyssey to employ Evotec’s high‑throughput experimentation and machine‑learning analysis to find small‑molecule treatments for autoimmune and inflammatory diseases, with Evotec receiving milestone payments for validated hit series. This move underscores a shift toward generating revenue directly from the AI‑based discovery process rather than from final products, reinforcing the trend of expanding AI‑centric collaborations across the biotech sector. ## Timeline ### 2026-08-06: Evotec partners with Odyssey Therapeutics to use AI for drug discovery Evotec will provide its AI‑driven discovery platform to Odyssey Therapeutics for autoimmune and inflammatory disease targets, earning milestone payments for each validated hit series. 4 sources. https://clstr.news/cluster/evotec-partners-with-odyssey-therapeutics-to-use-ai-for-drug-discovery ### 2026-07-22: Evogene‑ELEO and Evotec‑QIAGEN unveil AI‑driven biotech collaborations Evogene‑ELEO partner to develop oral PCSK9 drugs, while Evotec‑QIAGEN integrate multi‑omics data platforms, both leveraging AI to speed biotech research. 2 sources. https://clstr.news/cluster/evogeneeleo-and-evotecqiagen-unveil-aidriven-biotech-collaborations --- Cite as: AI-driven biotech partnership expansion. CLSTR, https://clstr.news/situations/ai-driven-biotech-partnership-expansion